Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Impel Pharmaceuticals Inc (NQ: IMPL ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Dec 15, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Impel Pharmaceuticals Inc < Previous 1 2 3 4 5 6 Next > Why Domino's Pizza Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session February 23, 2023 Gainers Via Benzinga Impel Pharmaceuticals Announces Strategic Repriortization, Continues Focus on Maximizing Trudhesa® Commercial Opportunity February 22, 2023 From Impel Pharmaceuticals Via GlobeNewswire Stocks That Hit 52-Week Lows On Thursday October 20, 2022 Thursday saw 177 companies set new 52-week lows. Via Benzinga Impel Pharmaceuticals: Q1 Earnings Insights May 16, 2022 Impel Pharmaceuticals (NASDAQ:IMPL) reported its Q1 earnings results on Monday, May 16, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Via Benzinga Earnings Scheduled For May 16, 2022 May 16, 2022 Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand. Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session February 20, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Wednesday November 16, 2022 On Wednesday, 70 companies set new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday November 15, 2022 On Tuesday, 34 companies set new 52-week lows. Via Benzinga Impel Pharmaceuticals Announces Third Quarter 2022 Financial Results and Provides Corporate Update November 14, 2022 From Impel Pharmaceuticals Via GlobeNewswire Impel Pharmaceuticals to Participate in Guggenheim 4th Annual Immunology and Neurology Day November 08, 2022 From Impel Pharmaceuticals Via GlobeNewswire Impel Pharmaceuticals to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022 November 07, 2022 From Impel Pharmaceuticals Via GlobeNewswire Impel NeuroPharma's Return On Capital Employed Insights September 09, 2022 According to data from Benzinga Pro, during Q2, Impel NeuroPharma's (NASDAQ:IMPL) reported sales totaled $2.80 million. Despite a 6.55% increase in earnings, the company posted a loss of $25.20... Via Benzinga Impel Pharmaceuticals: Q2 Earnings Insights August 15, 2022 Impel Pharmaceuticals (NASDAQ:IMPL) reported its Q2 earnings results on Monday, August 15, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Via Benzinga Earnings Outlook For Impel NeuroPharma August 12, 2022 Impel NeuroPharma (NASDAQ:IMPL) is set to give its latest quarterly earnings report on Monday, 2022-08-15. Here's what investors need to know before the announcement. Via Benzinga Recap of Tuesday's Biotech Catalysts - End Of The Day Summary July 19, 2022 The U.S. Food and Drug Administration (FDA) has granted tentative approval to Avadel Pharmaceuticals’ (NASDAQ: AVDL) lead candidate LUMRYZ (FT218) for the treatment of excessive daytime sleepiness... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022 August 25, 2022 Upgrades Via Benzinga Impel Commences Mid-Stage Autism Spectrum Disorder Study July 19, 2022 Impel Pharmaceuticals (NASDAQ: IMPL) has dosed the first patient in a Phase 2a proof-of-concept study of INP105, nasal olanzapine, a widely used atypical, second-generation antipsychotic. Via Benzinga Impel NeuroPharma's Return On Capital Employed Insights June 21, 2022 Impel NeuroPharma (NASDAQ:IMPL) brought in sales totaling $1.76 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 9.0%, resulting in a loss of $26.97 million. Via Benzinga Earnings Scheduled For August 15, 2022 August 15, 2022 Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter. Via Benzinga Mizuho Remains Bullish On This Small-Cap Stock's Migraine Candidate, But Why Did It Cut Price Target May 13, 2022 Mizuho Securities says that the Satsuma Pharmaceuticals Inc (NASDAQ: STSA) story is essentially unchanged. It remains bullish on STS101's potential as an effective, safe, and reliable intranasal... Via Benzinga Impel NeuroPharma Earnings Preview May 13, 2022 Impel NeuroPharma (NASDAQ:IMPL) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Impel... Via Benzinga 66 Biggest Movers From Yesterday May 03, 2022 Gainers Better Therapeutics, Inc. (NASDAQ: BTTX) shares surged 120.4% to close at $2.01 on Monday following a 5% drop on Friday. SoundHound AI, Inc. (NASDAQ: SOUN) shares surged... Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session March 24, 2022 Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV) shares moved upwards by 55.5% to $2.13 during Thursday's pre-market session. The market value of their outstanding... Via Benzinga Earnings Scheduled For March 24, 2022 March 24, 2022 Companies Reporting Before The Bell • iHuman (NYSE:IH) is likely to report earnings for its fourth quarter. • Pioneer Muni High Inc (NYSE:MAV) is expected to... Via Benzinga Benzinga's After-Hours Movers & News: Williams-Sonoma, PagerDuty And More March 16, 2022 Benzinga’s “After-Hours Movers & News” highlights the biggest movers of the day. The information on the price action is collected using Benzinga Pro's... Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session March 16, 2022 Gainers Via Benzinga Impel Neuro's Trudhesa Nasal Spray Migraine Treatment Performed Better Than Expected In Q4 January 18, 2022 Impel NeuroPharma Inc (NASDAQ: IMPL) stated that since the October 2021 commercial launch, the performance of Trudhesa has exceeded expectations with over 4,200... Via Benzinga 41 Stocks Moving In Monday's Mid-Day Session November 15, 2021 Gainers Casper Sleep Inc. (NYSE: CSPR) shares climbed 87.1% to $6.64 after the company agreed to be acquired by Durational Capital Management. The company also reported Q3... Via Benzinga Earnings Scheduled For November 15, 2021 November 15, 2021 Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its third quarter. • Tyson Foods (NYSE:TSN) is estimated to... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session September 28, 2021 Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) shares increased by 35.02% to $7.22 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is... Via Benzinga < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.